OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
OrthoPediatrics (Nasdaq: KIDS) will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OrthoPediatrics (Nasdaq: KIDS) will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. The company will host a conference call the same day at 4:30 p.m. ET to discuss the results.
Investors can access a live and archived webcast on the company's Investors page in the Events & Presentations section; the replay will be available for at least 90 days.
Details
News Market Reaction – KIDS
On Feb 13, the first trading day after this news, KIDS closed 1.02% above the previous close.
Data tracked by StockTitan Argus for the Feb 13 session.
Key Figures
- Earnings release date
- February 26, 2026
- Scheduled Q4 and full-year 2025 financial results release
- Conference call time
- 4:30 p.m. ET
- Start time for earnings conference call on February 26, 2026
- Webcast replay duration
- 90 days
- Replay availability period for the earnings webcast
Historical Context
-
FDA 510(k) clearance expanding iotaSOFT use to younger patients.
-
Record preliminary 2025 revenue and introduction of 2026 revenue guidance.
-
Launch of two PediHip bracing systems for pediatric hip conditions.
-
Participation in several healthcare investor conferences with webcast access.
-
Q3 revenue growth and higher adjusted EBITDA alongside ongoing net losses.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARSAW, Ind., Feb. 12, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after the market closes. OrthoPediatrics will host a conference call on Thursday, February 26, 2026 at 4:30 p.m. ET to discuss the results.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be available for replay for at least 90 days after the event.
About OrthoPediatrics Corp.
Founded in 2006, OrthoPediatrics is an orthopedic company focused exclusively on advancing the field of pediatric orthopedics. As such, it has developed the most comprehensive product offering to the pediatric orthopedic market to improve the lives of children with orthopedic conditions. OrthoPediatrics currently markets over 85 products that serve three of the largest categories within the pediatric orthopedic market. This product offering spans trauma and deformity, scoliosis, and sports medicine/other procedures. OrthoPediatrics’ global sales organization is focused exclusively on pediatric orthopedics and distributes its products in the United States and over 75 countries outside the United States. For more information, please visit www.orthopediatrics.com. For more information about the OrthoPediatrics Specialty Bracing portfolio, please visit www.opsb.com.
Investor Contact
Philip Trip Taylor
Gilmartin Group
philip@gilmartinir.com
415-937-5406
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.